Literature DB >> 109525

A monoclonal IgG4 (lambda) with factor V inhibitory activity.

P E Hurtubise, M C Coots, D J Jacob, A F Muhleman, H I Glueck.   

Abstract

A monoclonal IgG4 (lambda) with inhibitory activity to human coagulation factor V was isolated from the serum of a patient with a fatal hemorrhagic diathesis by using a combination of DE-52 ion exchange chromatography and isoelectric focusing techniques. Using the criteria for defining a monoclonal immunoglobulin of restricted mobility on protein electrophoresis, immunoelectrophoresis, and isoelectric focusing, as well as neutralization with class, subclass, and light chain type antisera, we are the first to demonstrate a factor V inhibitor as a monoclonal IgG4 (lambda) detectable in serum or plasma.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 109525

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  6 in total

1.  An endothelial cell-dependent pathway of coagulation.

Authors:  D Stern; P Nawroth; D Handley; W Kisiel
Journal:  Proc Natl Acad Sci U S A       Date:  1985-04       Impact factor: 11.205

2.  Inhibition of thromboxane A2 synthesis in human platelets by coagulation factor Xa.

Authors:  A K Sinha; A K Rao; J Willis; R W Colman
Journal:  Proc Natl Acad Sci U S A       Date:  1983-10       Impact factor: 11.205

3.  Biosynthesis of factor V in isolated guinea pig megakaryocytes.

Authors:  H C Chiu; P K Schick; R W Colman
Journal:  J Clin Invest       Date:  1985-02       Impact factor: 14.808

4.  Characterization of an acquired inhibitor to coagulation factor V. Antibody binding to the second C-type domain of factor V inhibits the binding of factor V to phosphatidylserine and neutralizes procoagulant activity.

Authors:  T L Ortel; M A Quinn-Allen; L A Charles; D Devore-Carter; W H Kane
Journal:  J Clin Invest       Date:  1992-12       Impact factor: 14.808

5.  Isolation and study of an acquired inhibitor of human coagulation factor V.

Authors:  M E Nesheim; W L Nichols; T L Cole; J G Houston; R B Schenk; K G Mann; E J Bowie
Journal:  J Clin Invest       Date:  1986-02       Impact factor: 14.808

6.  Heterogeneity of human factor V deficiency. Evidence for the existence of antigen-positive variants.

Authors:  H C Chiu; E Whitaker; R W Colman
Journal:  J Clin Invest       Date:  1983-08       Impact factor: 14.808

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.